RSVI-301

N/A

Report date: 2022/04/02 11:35:23

Base Information

Drug NameRSVI-301
Drug Alias NameRSVI-301
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRosVivo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And CompanyRosVivo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsObesityDiabetes MellitusMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A